Inactive Instrument
Epigenomics AG Stock Deutsche Boerse AG
Stocks
DE000A0BVT96
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Deutsche Boerse AG
|
||
| - EUR | - |
|
| 09-03 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 798K 915K 752K 685K 1.28M 87.69M 1.28M 9M 3.47M 44.67M 3.44M 3.36M 144M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.77M 13.49M 11.08M 10.09M 18.92M 1.29B 18.94M 133M 51.15M 659M 50.69M 49.56M 2.12B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 2023-02-28 |
Alexander Link
BRD | Director/Board Member | 55 | 2020-05-31 |
Jochen Hummel
BRD | Director/Board Member | 56 | 2024-02-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.59% | +10.04% | +397.07% | +102.38% | 4.62B | |
| -2.62% | +12.43% | +108.53% | +437.84% | 4.45B | |
| +4.33% | +0.75% | +21.72% | +83.72% | 3.34B | |
| +0.93% | +3.74% | +272.38% | +601.03% | 2.81B | |
| +6.75% | +15.41% | -16.39% | -19.04% | 2.43B | |
| -2.98% | +10.96% | +56.60% | - | 1.78B | |
| +0.89% | +6.73% | +28.20% | +62.00% | 1.13B | |
| +2.87% | +7.26% | +165.56% | -28.59% | 1.07B | |
| +5.23% | +1.37% | -15.35% | +65.52% | 604M | |
| Average | +1.65% | +7.58% | +113.15% | +163.11% | 2.47B | |
| Weighted average by Cap. | +0.95% | +8.64% | +153.61% | +216.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.53K 22.6K 20.59K 38.6K 2.64M 38.64K 271K 104K 1.34M 103K 101K 4.33M |
| Net income | -3.35M -3.84M -3.16M -2.88M -5.39M -368M -5.4M -37.81M -14.57M -188M -14.44M -14.12M -605M | -314K -360K -296K -269K -505K -34.5M -506K -3.54M -1.37M -17.58M -1.35M -1.32M -56.71M |
| Net Debt | 10.46M 11.99M 9.85M 8.97M 16.81M 1.15B 16.83M 118M 45.45M 585M 45.04M 44.04M 1.89B | 10.97M 12.58M 10.33M 9.41M 17.64M 1.21B 17.66M 124M 47.68M 614M 47.25M 46.2M 1.98B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
